GBA1 and Parkinson disease: Many studies have approached this question by targeting components of the GBA1/lysosomal pathway32 with a view to delineating mechanistic pathways or to alleviating disease symptoms, but our approach has been to attempt to gain as wide a picture as possible by unbiased approaches such as lipidomics and proteomics analyses of brain tissue from IPD and PD-GBA patients.